![Iris Löw-Friedrich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 215 653 $ al 31/05/2026
La Dra. Iris Lw-Friedrich es vicepresidenta del Consejo de Supervisión de Evotec SE, directora médica y vicepresidenta ejecutiva de UCB SA y profesora de la Johann Wolfgang Goethe-Universitt Frankfurt am Main. Forma parte del Consejo de Administración de Fresenius SE & Co. KGaA y Evotec SE. Anteriormente, la Dra. Lw-Friedrich fue presidenta de Transcelerate Biopharma, Inc., miembro del Consejo de Supervisión de Heidelberg Pharma AG, directora de Investigación y Desarrollo de UCB Pharma GmbH, vicepresidenta de Proyectos Globales de BASF Pharma, vicepresidenta de Desarrollo Clínico de Hoechst AG, directora de Gestión Clínica Global y vicepresidenta de Aventis Pharma AG y vicepresidenta de Desarrollo Clínico de Hoechst Marion Roussel, Inc. Se doctoró en la Johann Wolfgang Goethe-Universitt Frankfurt am Main.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EVOTEC SE 0,02 % | 31/12/2025 | 35.000 ( 0,02 % ) | 215 653 $ | 31/05/2026 |
| 30/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FRESENIUS SE & CO. KGAA | Director/Miembro de la Junta | 13/05/2016 |
| SWEDISH ORPHAN BIOVITRUM AB | Director/Miembro de la Junta | 08/05/2025 |
| SATELLOS BIOSCIENCE INC. | Director/Miembro de la Junta | 18/06/2025 |
| FINANCIÈRE DE TUBIZE S.A. | Director/Miembro de la Junta | 24/09/2025 |
| BIONTECH SE | Director/Miembro de la Junta | 15/05/2026 |
Celosia Therapeutics Pty Ltd.
 Celosia Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which uses gene therapy to treat neurodegenerative diseases | Presidente | - |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Director/Miembro de la Junta | 01/04/2019 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2000 |
| Empresas | Cargo | Fin |
|---|---|---|
| EVOTEC SE | Presidente | 11/06/2026 |
| ░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 20 |
|---|---|
Fresenius SE & Co. KGaA
 Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
BASF SE
 BASF SE Chemicals: SpecialtyProcess Industries Manufactures plastic materials, precursors, chemicals for batteries, automotive OEM coatings, petrochemicals, intermediates, agrochemicals, industrial, nutrition & care additives | Process Industries |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Financière de Tubize SA
 Financière de Tubize SA Financial ConglomeratesFinance Operates as an investment holding company which invests in the chemical, pharmaceutical and film sectors | Finance |
Johann Wolfgang Goethe-Universität Frankfurt am Main
Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aventis Pharma AG | |
Hoechst Marion Roussel, Inc.
 Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
BASF Pharma | |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Satellos Bioscience, Inc.
 Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
Frankfurt University Medical School
 Frankfurt University Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celosia Therapeutics Pty Ltd.
Celosia Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which uses gene therapy to treat neurodegenerative diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
